$NVAX

$10.42▲ +0.9% YTD

9 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

CP $10.42▲ +0.9%Oct 29, 2026 · ThinkSabio Blog

$NVAX NVAX - Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe…

News

NVAX ▼ -0.4% - Novavax, Inc.

CP $10.29▲ -0.4%Oct 29, 2026 · ThinkSabio Blog

$NVAX NVAX - Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026…

SEC 13D/G

NVAX - Novavax, Inc. - SEC Filing Update (16-OCT-2026) | ThinkSabio - Stocks Simplified

$11.20▲ 56.86%Oct 16, 2026 · ThinkSabio Blog

$NVAX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NVAX Novavax, Inc. : $11.20 Sector: Healthcare | YTD: 🔼+ 56.86%…

News

NVAX ▲ +25.9% - Novavax, Inc.

CP $13.18▲ +25.9%Oct 5, 2026 · ThinkSabio Blog

$NVAX highs…

News

NVAX ▲ +16.2% - Novavax, Inc.

CP $12.17▲ +16.2%Oct 5, 2026 · ThinkSabio Blog

$NVAX highs…

News

NVAX ▲ +7.0% - Novavax, Inc.

CP $11.20▲ +7.0%Oct 5, 2026 · ThinkSabio Blog

$NVAX highs following morning Covid and Russia plague headlines…

News

NVAX ▲ +1.1% - Novavax, Inc.

CP $10.22▲ +1.1%Sep 2, 2026 · ThinkSabio Blog

$NVAX NVAX - Novavax to Participate in September Investor Conferences…

News

NVAX ▲ +0.8% - Novavax, Inc.

CP $9.12▲ +0.8%Aug 28, 2026 · ThinkSabio Blog

$NVAX NVAX - Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccina…

SEC 13D/G

NVAX - Novavax, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$7.86▲ 10.08%Aug 7, 2026 · ThinkSabio Blog

$NVAX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NVAX Novavax, Inc. : $7.86 Sector: Healthcare | YTD: 🔼+ 10.08%…